COMP <GO>
LQDA vs TNGX // FORWARD P/E MULTIPLE
Liquidia Corporation (NASDAQ) VS. Tango Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: LQDA 9
— TNGX 1
▲ FORWARD P/E MULTIPLE LEADER: LQDA
LAST: $41.85 (-7.12%) • MKT CAP: $4.03B
forward-pe
21.0x
LAST: $21.76 (-4.22%) • MKT CAP: $3.83B
forward-pe
28.0x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LQDA VS. TNGX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LQDA | TNGX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -12.60% | -28.90% | +16.30 | LQDA | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.99% | -3.68% | +2.69 | LQDA | /fcf-yield <GO> |
| Operating Margin | -32.50% | -60.00% | +27.50 | LQDA | /operating-margins <GO> |
| Net Profit Margin | -43.50% | -60.00% | +16.50 | LQDA | /net-margins <GO> |
| Revenue Growth (YoY) | 180.00% | 48.30% | +131.70 | LQDA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.33 | 26.00 | -19.67 | TNGX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 5/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.5 | 46.9 | +5.60 | LQDA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.90 | 0.87 | +0.03 | LQDA | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 21.0x | 28.0x | -7.00 | LQDA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.03B | $3.83B | $202.4M | LQDA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LQDA REV | TNGX REV | LQDA GROSS % | TNGX GROSS % | LQDA FCF | TNGX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $158.3M | $62.4M | — | — | -$40.0M | -$139.9M |
| FY 2024 | $14.0M | $42.1M | 58.0% | — | -$98.4M | -$132.3M |
| FY 2023 | $17.5M | $36.5M | — | — | -$42.4M | -$119.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LQDA // BETA 0.90
TNGX // BETA 0.87